SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-19-008366
Filing Date
2019-07-19
Accepted
2019-07-19 17:21:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)5 azrx424b5.htm 424B5 679547
2 IMAGE azurrx.jpg GRAPHIC 3463
  Complete submission text file 0001654954-19-008366.txt   685504
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B5 | Act: 33 | File No.: 333-231954 | Film No.: 19964160
SIC: 2834 Pharmaceutical Preparations